These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 82578

  • 1. Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.
    Perry LL, Benacerraf B, Greene MI.
    J Immunol; 1978 Dec; 121(6):2144-7. PubMed ID: 82578
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antigen-specific T cell-mediated suppression. II. In vitro induction by I-J-coded L-glutamic acid50-L-tyrosine50 (GT)-specific T cell suppressor factor (GT-T8F) of suppressor T cells (T82) bearing distinct I-J determinants.
    Germain RN, Theze J, Waltenbaugh C, Dorf ME, Benacerraf B.
    J Immunol; 1978 Aug; 121(2):602-7. PubMed ID: 79609
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
    Greene MI, Fujimoto S, Sehon AH.
    J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
    [Abstract] [Full Text] [Related]

  • 5. Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen.
    Carter RH, Drebin JA, Schatten S, Perry LL, Greene MI.
    J Immunol; 1983 Feb; 130(2):997-1002. PubMed ID: 6184410
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM.
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [Abstract] [Full Text] [Related]

  • 11. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH, Daynes RA, Hodes RJ.
    J Immunol; 1986 Feb 15; 136(4):1521-7. PubMed ID: 2418117
    [Abstract] [Full Text] [Related]

  • 12. Hapten-specific responses to the phenyltrimethylamino hapten. V. A single chain antigen-binding I-J+ first-order T suppressor factor requires antigen to induce anti-idiotypic second-order suppressor T cells.
    Jayaraman S, Bellone CJ.
    J Immunol; 1985 Feb 15; 134(2):1010-8. PubMed ID: 3155532
    [Abstract] [Full Text] [Related]

  • 13. Genetic and biological characterization of a T suppressor cell induced by anti-idiotypic antibody.
    Monroe JG, Gurish M, Dambrauskas J, Slaoui M, Lowy A, Greene MI.
    J Immunol; 1985 Sep 15; 135(3):1589-97. PubMed ID: 3160770
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the immune response to tumor antigens. X. Activation of third-order suppressor T cells that abrogate anti-tumor immune responses.
    Schatten S, Drebin JA, Perry LL, Chung W, Greene MI.
    J Immunol; 1984 Aug 15; 133(2):1064-9. PubMed ID: 6234349
    [Abstract] [Full Text] [Related]

  • 15. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD.
    J Immunol; 1984 Dec 15; 133(6):3112-20. PubMed ID: 6208271
    [Abstract] [Full Text] [Related]

  • 16. Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.
    Malkovský M, Asherson GL, Chandler P, Colizzi V, Watkins MC, Zembala M.
    J Immunol; 1983 Feb 15; 130(2):785-90. PubMed ID: 6217254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN.
    J Immunol; 1984 May 15; 132(5):2649-57. PubMed ID: 6201554
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.